FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Inspection Report Cites Masimos Complaint Probes

[ Price : $8.95]

A just-released FDA Form-483 says Irvine, CA-based device maker Masimo failed to adequately investigate complaints about potential...

FDA Posts 9 Updated and 3 New MedGuides

[ Price : $8.95]

FDA updates its Medication Guides Web page to add nine updated and three new guides.

FDA Denies Petition Seeking Restrictions on N-methyl Pyrrolidone

[ Price : $8.95]

FDA rejects a citizen petition from Neurelis that asked FDA to refrain from approving any intranasal product for treating epilepsy...

Generic Drug Regulatory Science Eyes Post-market Evaluations

[ Price : $8.95]

CDER says generic drug post-market evaluations and complex products equivalence top the list of fiscal year 2015 regulatory scienc...

Novartis Faces Anti-kickback Charges in Whistleblower Suit

[ Price : $8.95]

U.S. federal judge Paul Gardephe denies a Novartis motion to dismiss anti-kickback claims in a whistleblower suit originally filed...

FDA Seeks Injunction Against Pharmaceutical Innovations

[ Price : $8.95]

FDA seeks a permanent injunction to stop Pharmaceutical Innovations Inc., and its principal officer, Gilbert Buchalter, from manuf...

Info on E-Records/Signatures Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on electronic record and signatures to the Office of Man...

Guidance on Laboratory Developed Test Oversight

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).

Panel to Discuss Vertex Pharma sNDA for Cystic Fibrosis

[ Price : $8.95]

Federal Register Notice: FDAs Pulmonary-Allergy Drugs Advisory Committee will meet 10/21 to discuss a Vertex Pharmaceuticals sNDA ...

Panel to Discuss Epidural Steroid Injections

[ Price : $8.95]

Federal Register Notice: FDAs Anesthetic and Analgesic Drug Products Advisory Committee will meet 11/24-25 to discuss risks with e...